Life-science logistics specialist opens Los Angeles location

Life-science-logistics-specialist-opens-Los-Angeles-location.jpg
(kevinjeon00/iStock via Getty Images Plus) (Getty Images)

Biocair has expanded its pharmaceutical and clinical trial logistics operations with new location in California, near Los Angeles International Airport.

Biocair (a global company offering clinical trial, pharmaceutical, and cell and gene therapy logistics solutions) has continued its expansion with a new location in Los Angeles. Located close to Los Angeles International Airport, the facility is intended to meet the growing demand for life-sciences service infrastructure across the US.

The move marks the latest investment in Biocair’s global infrastructure during the COVID-19 pandemic. The firm also has opened facilities in South Africa, Frankfurt, Germany, and India.

Features of the new facility include a dedicated cell and gene therapy packaging station, reportedly constructed to meet the strict requirements for handling such materials. It also offers new packaging equipment manufactured by SavSu and a liquid nitrogen service station that facilitates cold-transport needs.

Steve Canales, operations manager of Biocair’s office, commented that the capabilities and strategic location stand to serve customers with specialized requirements.

We are very excited about what this new space offers, especially for our customers looking to ship cell and gene therapies and other time- and temperature-sensitive materials,” he said. “With more than triple the square footage as our previous space, we are improving the safety, efficiency, and scalability of our entire operation.”

Prior to the Los Angeles location, Biocair’s most recently opened site was its facility in Cape Town, South Africa, which opened in July. Leonard Lazarus, Biocair’s regional director for South Africa and India, said the opening of this and other global locations meets the expanding needs of researchers across the globe.

Biocair is able to provide our industry-leading global logistics services because we continually invest in our global network, the latest technologies and we surround ourselves with experts in the life sciences industry,” said Lazarus. “This latest investment in the new Cape Town office complements our existing facilities in Durban and Johannesburg, further improving Biocair’s operational capacity to meet the needs of the scientific community in South Africa and further afield.”

Biocair recently opened a new office in Chicago, bringing the total number of US offices to nine. That facility accommodates certified packaging and conditioning areas for a wide range of temperatures, including a liquid nitrogen service station.